NASDAQ Companies

Page: 1 of 60
Exchange:   NASDAQ
Displaying 1-50 of 2974 results Download this list
Name Symbol Market Cap ADR TSO Country IPO Year Subsector
1347 Capital Corp. $56.45M United States 2014 Business Services
1347 Capital Corp. n/a United States 2014 Business Services
1347 Capital Corp. $41.84M United States 2014 n/a
1347 Capital Corp. n/a United States 2014 Business Services
1347 Property Insurance Holdings, Inc. $50.36M United States 2014 Property-Casualty Insurers
2U, Inc. $721.98M United States 2014 Computer Software: Prepackaged Software
Abengoa Yield plc $2.62B United Kingdom 2014 Electric Utilities: Central
Achaogen, Inc. $163.82M United States 2014 Major Pharmaceuticals
Adamas Pharmaceuticals, Inc. $246.85M United States 2014 Major Pharmaceuticals
Affimed N.V. $105.77M Germany 2014 n/a
Agile Therapeutics, Inc. $126.25M United States 2014 Major Pharmaceuticals
Akebia Therapeutics, Inc. $399.59M United States 2014 Major Pharmaceuticals
Akers Biosciences Inc $17.79M n/a 2014 Biotechnology: In Vitro & In Vivo Diagnostic Substances
Alcentra Capital Corp. $171.8M United States 2014 n/a
Alder BioPharmaceuticals, Inc. $505.18M United States 2014 Major Pharmaceuticals
Aldeyra Therapeutics, Inc. $43.47M United States 2014 Major Pharmaceuticals
Amedica Corporation $32.27M United States 2014 Medical/Dental Instruments
American Capital Senior Floating, Ltd. $130.3M United States 2014 n/a
Amphastar Pharmaceuticals, Inc. $449.57M United States 2014 Major Pharmaceuticals
Anchor BanCorp Wisconsin Inc. $280.55M United States 2014 n/a
Applied Genetic Technologies Corporation $308.25M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Aquinox Pharmaceuticals, Inc. $72.94M Canada 2014 Major Pharmaceuticals
AR Capital Acquisition Corp. n/a United States 2014 n/a
Ardelyx, Inc. $395.69M United States 2014 Major Pharmaceuticals
Argos Therapeutics, Inc. $183.58M United States 2014 Major Pharmaceuticals
Atara Biotherapeutics, Inc. $288.91M n/a 2014 n/a
Auris Medical Holding AG $131.74M Switzerland 2014 Major Pharmaceuticals
Auspex Pharmaceuticals, Inc. $748.9M United States 2014 Major Pharmaceuticals
Avalanche Biotechnologies, Inc. $761.64M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Bankwell Financial Group, Inc. $123.63M United States 2014 Major Banks
Bio Blast Pharma Ltd. $83.68M Israel 2014 Major Pharmaceuticals
Biocept, Inc. $12.55M United States 2014 Medical Specialities
Blue Hills Bancorp, Inc. $375.48M n/a 2014 Major Banks
Borderfree, Inc. $334.3M United States 2014 Business Services
Boulevard Acquisition Corp. $263.77M United States 2014 Business Services
Boulevard Acquisition Corp. $275.63M United States 2014 Business Services
Boulevard Acquisition Corp. n/a United States 2014 Business Services
Calithera Biosciences, Inc. $197.41M United States 2014 n/a
CAMBRIDGE CAPITAL ACQUISITION CORPORATION $102.08M United States 2014 Business Services
CAMBRIDGE CAPITAL ACQUISITION CORPORATION n/a United States 2014 Business Services
Cara Therapeutics, Inc. $184.78M United States 2014 Major Pharmaceuticals
CareDx, Inc. $67.34M United States 2014 Medical Specialities
Celladon Corporation $239.44M n/a 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Cerulean Pharma Inc. $79.69M United States 2014 Major Pharmaceuticals
CM Finance Inc $180.4M United States 2014 n/a
Coastway Bancorp, Inc. $53.5M United States 2014 Savings Institutions
Concert Pharmaceuticals, Inc. $248.23M United States 2014 Major Pharmaceuticals
ContraFect Corporation $68.27M United States 2014 n/a
ContraFect Corporation n/a United States 2014 n/a
ContraFect Corporation n/a United States 2014 n/a
*IPO year information is not available for stocks prior to 1970.